You can develop innovative technologies and informatics tools for cancer metabolomics research by applying to any of the following NCI-reissued funding opportunities:

• Develop innovative methods and algorithms in biomedical computing, informatics, and data science (R21).
• Conduct early-stage development of informatics technologies, from prototyping to hardening and adaptation (U01).
• Enhance and disseminate emerging technologies to improve cancer research data (U24).
• Develop and sustain high-value tools for improving data acquisition and accessibility (U24).

Refer to the details on specific areas through the Notice of Special Interest, and apply by June 13, 2023.

Metabolites and lipids play key roles in keeping cells healthy and functioning, so improving metabolomics technologies and their accessibility to researchers is advantageous for the advancement of cancer research.